Related Experiment Videos

Frequency of multiple sclerosis in Valle d'Aosta, 1971-1985

L Sironi1, A Mamoli, G D'Alessandro

  • 1Neurology and Neurophysiopathology Department, Aosta Regional Hospital, Italy.

Neuroepidemiology
|January 1, 1991
PubMed

Insights

Multiple Sclerosis (MS) prevalence in Italy is increasing, now exceeding 30 cases per 100,000. A study in Valle d'Aosta found high MS incidence and prevalence, suggesting Italy is a medium-high risk country for this neurological disease.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Multiple Sclerosis (MS) prevalence in Italy was historically considered low, with pre-1980 rates between 7.2-27.1 per 100,000.
  • Recent studies indicate a rise in MS prevalence, consistently above 30 per 100,000 inhabitants.
  • This suggests a potential shift in Italy's risk classification for MS from low to medium-high.

Purpose of the Study:

  • To investigate the prevalence and incidence of Multiple Sclerosis (MS) in Valle d'Aosta, Italy.
  • To assess if Valle d'Aosta's unique characteristics make it a suitable epidemiological model for MS research.
  • To determine the current MS risk level in Italy based on regional data.

Main Methods:

  • Conducted a prevalence and incidence survey in the Valle d'Aosta region.
  • Collected epidemiological data on Multiple Sclerosis (MS) cases.
  • Utilized Valle d'Aosta as an epidemiological model due to its specific regional features.

Main Results:

  • The mean annual incidence of MS in Valle d'Aosta was recorded at 2.1 cases per 100,000 inhabitants.
  • On December 31, 1985, the prevalence of MS in the region was 39 cases per 100,000 inhabitants.
  • These findings indicate that MS rates in Valle d'Aosta are comparable to high-risk areas in Europe.

Conclusions:

  • The study confirms that MS incidence and prevalence in Valle d'Aosta are significantly elevated.
  • Italy should be reclassified as a medium-high risk country for Multiple Sclerosis.
  • Further epidemiological surveillance is warranted to monitor MS trends across Italy.

Related Concept Videos